MYRX (Myrexis) Other Current Payables: $0.00 Mil (As of Jun. 2013)


What is Myrexis Other Current Payables?

Myrexis MYRX Other Current Payables is $0.00 Mil as of Jun. 2013.

Myrexis's Other Current Payables for the quarter that ended in Jun. 2013 was $0.00 Mil.

Myrexis Other Current Payables Related Terms

Myrexis Other Current Payables Historical Data

* Premium members only.

The historical data trend for Myrexis's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Myrexis Other Current Payables Chart

Myrexis Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13
Other Current Payables
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Myrexis Quarterly Data
Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Myrexis Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
Myrexis (MYRX) has a Other Current Payables of $0.00 Mil as of Jun. 2013. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Myrexis and its competitors.
Is Myrexis' Other Current Payables too high?
Myrexis' current Other Current Payables is $0.00 Mil.
How does Myrexis' Other Current Payables compare to MGHL and NTWN?
Myrexis' Other Current Payables of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Diversified Financial Services company?
A good Other Current Payables depends on the Diversified Financial Services industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Myrexis and its competitors. Myrexis's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Myrexis stock overvalued right now?
Myrexis (MYRX) has a current Other Current Payables of $0.00 Mil. The current Other Current Payables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Myrexis (MYRX), the current Other Current Payables is $0.00 Mil as of Jun. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Myrexis Business Description

Address 600 Fifth Avenue, 2nd Floor, New York, NY, USA, 10020
Myrexis Inc is engaged in evaluating strategic alternatives, such as identifying, evaluating and making financial investments in life sciences assets.